Raman Singh Sells 9,024 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) Director Raman Singh sold 9,024 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $68.62, for a total transaction of $619,226.88. Following the completion of the transaction, the director owned 44,637 shares in the company, valued at approximately $3,062,990.94. This represents a 16.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Raman Singh also recently made the following trade(s):

• On Monday, September 14th, Raman Singh sold 8,468 shares of Liquidia stock. The stock was sold at an average price of $66.16, for a total transaction of $560,242.88.

Liquidia Stock Up 0.6%

Shares of NASDAQ:LQDA traded up $0.41 during trading on Tuesday, reaching $65.72. 1,372,017 shares of the company traded hands, compared to its average volume of 1,724,839. The firm has a fifty day simple moving average of $77.19 and a 200 day simple moving average of $59.67. The company has a quick ratio of 2.12, a current ratio of 2.31 and a debt-to-equity ratio of 0.63. Liquidia Corporation has a 1-year low of $21.15 and a 1-year high of $93.61. The firm has a market cap of $5.88 billion, a P/E ratio of 47.97 and a beta of 0.53.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). Liquidia had a return on equity of 149.65% and a net margin of 30.74%.The company had revenue of $171.68 million during the quarter, compared to analyst estimates of $168.48 million. During the same period last year, the company posted ($0.49) earnings per share. The company’s revenue was up 1842.1% compared to the same quarter last year. Analysts anticipate that Liquidia Corporation will post 2.57 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company raised their price target on Liquidia from $62.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, August 13th. Piper Sandler set a $129.00 price target on Liquidia in a research note on Friday, July 24th. BTIG Research increased their price objective on Liquidia from $109.00 to $111.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $106.00 price objective on shares of Liquidia in a research report on Thursday, August 13th. Finally, HC Wainwright set a $36.00 target price on shares of Liquidia in a research report on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $98.08.

Institutional Trading of Liquidia

Institutional investors and hedge funds have recently made changes to their positions in the stock. Covestor Ltd boosted its stake in shares of Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Liquidia by 7.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after acquiring an additional 422 shares in the last quarter. Quantinno Capital Management LP lifted its holdings in Liquidia by 3.6% in the 1st quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock worth $648,000 after purchasing an additional 589 shares during the last quarter. ProShare Advisors LLC lifted its holdings in Liquidia by 7.1% in the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock worth $405,000 after purchasing an additional 775 shares during the last quarter. Finally, Arizona State Retirement System boosted its position in Liquidia by 5.4% during the second quarter. Arizona State Retirement System now owns 17,627 shares of the company’s stock worth $1,405,000 after purchasing an additional 900 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

About Liquidia

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious cardiopulmonary conditions, including pulmonary arterial hypertension (PAH). The company is headquartered in Research Triangle Park, North Carolina, and serves healthcare providers and patients primarily in the United States.

Liquidia’s lead product is Yutrepia, an inhaled formulation of treprostinil designed for the treatment of PAH. The company has also developed treprostinil injection products and is pursuing additional therapies for rare cardiopulmonary diseases.